Emcure Pharmaceuticals, a leading player in India’s pharmaceutical sector, has officially opened its advanced Formulation Research and Development (R&D) Centre in Ahmedabad, Gujarat. The state-of-the-art facility, located near Tapovan Circle, will focus on pioneering research in complex drug delivery systems, including sustained-release formulations, liposomal injections, and advanced dermal therapies. The inauguration event was graced by Shri Rushikeshbhai Patel, Gujarat’s Minister of Health and Family Welfare, highlighting Emcure’s dedication to advancing healthcare through innovative drug development.
The Emcure Research Centre (ERC) is designed to drive pharmaceutical breakthroughs, featuring top-tier laboratories and cutting-edge equipment for a variety of dosage forms. The centre is equipped to handle all stages of pharmaceutical development, from early-stage formulation to scaling-up, while ensuring compliance with global regulatory standards.
A skilled team of 350 professionals, including PhDs, post-graduates, and graduates specializing in pharmaceutical sciences, bio-engineering, analytical chemistry, pharmacovigilance, and regulatory affairs, will work together to develop innovative formulations and enhance drug bioavailability.
Shri Rushikeshbhai Patel expressed pride in the opening of the new facility, stating, “This advanced R&D centre in Ahmedabad is a testament to Gujarat’s long-standing role as an innovation hub. Emcure’s commitment to drug research and the development of local talent is strengthening India’s position as a global pharmaceutical leader. I congratulate the team at Emcure on this remarkable achievement.”
The centre is also designed with sustainability in mind, incorporating green chemistry practices that reflect Emcure’s focus on environmentally responsible innovation. It will foster job creation and encourage collaborations with academic institutions, industry experts, and regulatory bodies, further promoting an ecosystem of growth and shared knowledge.
Satish Mehta, Founder and CEO of Emcure Pharmaceuticals, commented, “For over four decades, Emcure has been committed to breaking new ground in pharmaceutical research. This new centre marks an important milestone in our mission to create innovative solutions for unmet medical needs. By combining state-of-the-art technology with a talented team, we are poised to drive advancements that will shape the future of global healthcare.”
With its focus on developing differentiated products for regulated, emerging, and domestic markets, the ERC further solidifies Gujarat’s status as a pharmaceutical research hub. Emcure Pharmaceuticals Ltd. (EPL), headquartered in Pune, is a leading pharmaceutical company in India.
Since its inception in 1981, Emcure has been committed to research, development, and manufacturing of a broad range of pharmaceutical products aimed at improving patient health and well-being. With a presence in over 70 countries, including Europe and Canada, Emcure is ranked as the 12th largest pharma company in India as of June 2024.
